ArticleBMC cancer2025

NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label, randomised controlled trial.

Zhiguo Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.